InCaptus, LLC is addressing the collaboration gap in clinical drug development with the aim of providing insightful feedback from leading medical professionals. The startup, founded in 2013, is focused on bridging the divide between MDs and the Pharmaceutical and Biomedical industries throughout all phases of clinical drug development. Their mission is to add value to the industry by incentivizing 'Thought Leader' users to provide vital and accurate feedback to clients. InCaptus operates within the Enterprise Software, Health Care, and Clean Energy industries. As of now, there is no publicly available information about their last investment or the investors involved. With its unique approach to enhancing collaboration and driving innovation in clinical drug development, InCaptus presents a promising opportunity for venture capitalists seeking to invest in disruptive healthcare technology startups.
There is no investment information
No recent news or press coverage available for InCaptus, LLC.